Tucatinib and Trastuzumab in HER3-mutant and HER2-not Amplified Metastatic Breast Cancer

Primary location

Polyclinique Bordeaux Nord Aquitaine

Bordeaux, France

+8 additional locations

Contact

Sandra Clinical Project Manager